Charting the Future: Amicus Therapeutics Takes the Spotlight at Key Investor Conferences in September 2023!

PHILADELPHIA, Sept. 01, 2023 (GLOBE NEWSWIRE) – Get ready to be inspired as Amicus Therapeutics, Inc. (Nasdaq: FOLD) makes its mark on the global healthcare stage this September. Our leadership is taking the spotlight at two prestigious investor conferences, and we invite you to join us for a glimpse into the future of healthcare innovation.

First up, the Morgan Stanley 21st Annual Global Healthcare Conference in the heart of New York City on Monday, September 11, 2023, at 11:20 a.m. E.T. It’s not just a presentation; it’s a journey into the cutting edge of medical breakthroughs.

But that’s not all – mark your calendars for the Cantor Global Healthcare Conference 2023 in the vibrant city of New York, NY, on Wednesday, September 27, 2023, at 1:15 p.m. E.T. We’re not just attending; we’re shaping the future of healthcare.

Amicus Therapeutics isn’t just a company; we’re a force of innovation. Join us as we redefine the boundaries of healthcare and unveil the possibilities of tomorrow!

About Amicus Therapeutics

Pioneering Hope: Amicus Therapeutics (Nasdaq: FOLD) Ignites a Global Movement in the Pursuit of Rare Disease Cures!

In a world where rare diseases often remain in the shadows, Amicus Therapeutics stands as a beacon of unwavering dedication. We are not just a biotechnology company; we are the embodiment of hope for those living with rare diseases. Our mission is simple, yet profound – to discover, develop, and deliver life-changing medicines of unparalleled quality.

But we don’t just stop at innovation; we put patients at the heart of everything we do. Our relentless commitment is fueled by a desire to bring cutting-edge, first-of-its-kind medicines to those who need them most.

At Amicus Therapeutics, we’re not just pioneers; we’re trailblazers, charting a course towards a brighter, healthier future. Join us as we light up the path to hope and healing for patients worldwide.

Leave a Comment